For the year ending 2025-12-31, LPSN had -$88,233K decrease in cash & cash equivalents over the period. -$42,523K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -67,233 |
| Stock-based compensation expense | 14,256 |
| Depreciation and amortization | 21,975 |
| Reduction of operating lease right-of-use assets | 17 |
| Amortization of purchased intangible assets and finance leases | 757 |
| Amortization of debt issuance costs and accretion of debt discount | 7,614 |
| Impairment of goodwill | 41,595 |
| Impairment of intangibles and other assets | 2,108 |
| Change in fair value of warrants | -13,202 |
| Change in fair value of contingent consideration | 0 |
| Gain on troubled debt restructuring | 42,429 |
| Gain on debt extinguishment | 0 |
| Paid-in-kind interest | 15,263 |
| Allowance for credit losses | 866 |
| Loss (gain) on divestiture | 0 |
| Deferred income taxes | 622 |
| Equity loss in joint venture | 0 |
| Accounts receivable | -1,160 |
| Prepaid expenses and other current assets | -3,591 |
| Contract acquisition costs | -10,383 |
| Other assets | -34 |
| Accounts payable, accrued expenses and other current liabilities | -19,823 |
| Deferred revenue | -4,315 |
| Operating lease liabilities | -14 |
| Other liabilities | -3,660 |
| Net cash used in operating activities | -30,435 |
| Purchases of property and equipment, including capitalized internal-use software development costs | 12,088 |
| Proceeds from divestiture | 0 |
| Purchases of intangible assets | 1,639 |
| Net cash used in investing activities | -13,727 |
| Payment on settlement of warrants | 1,297 |
| Payment in connection with troubled debt restructuring | 45,000 |
| Proceeds from issuance of 2029 convertible senior notes | 0 |
| Repayments of convertible debt-Convertible Senior Notes Due2024 | 0 |
| Repayments of convertible debt-Convertible Senior Notes Due2026 | 0 |
| Payment of debt issuance costs | 0 |
| Principal payments for finance leases | 26 |
| Proceeds from issuance of common stock in connection with the exercise of options and espp | 820 |
| Net cash (used in) provided by financing activities | -45,503 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 1,432 |
| Net decrease in cash, cash equivalents, and restricted cash | -88,233 |
| Cash classified within current assets held for sale | 0 |
| Cash, cash equivalents, and restricted cash - beginning of year | 183,237 |
| Cash, cash equivalents, and restricted cash - end of year | 95,004 |
LIVEPERSON INC (LPSN)
LIVEPERSON INC (LPSN)